Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erector spinae block with ropivacaine for pain after total hip arthroplasty
ACTRN12619000071123Phase 4Completed
- Sponsor
- Dr Mark Lennon
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine erector spinae block with Saline placebo erector spinae block (2 arms). Primary endpoint: Pain score with movement of the operated leg. Started Feb 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12619000071123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000071123.